SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-001959
Filing Date
2021-01-05
Accepted
2021-01-05 16:15:57
Documents
14
Period of Report
2021-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d104157d8k.htm   iXBRL 8-K 29213
2 EX-99.1 d104157dex991.htm EX-99.1 48910
6 GRAPHIC g104157dsp01.jpg GRAPHIC 4659
  Complete submission text file 0001193125-21-001959.txt   220165

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210105.xsd EX-101.SCH 3059
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210105_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210105_pre.xml EX-101.PRE 11400
7 EXTRACTED XBRL INSTANCE DOCUMENT d104157d8k_htm.xml XML 3354
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 21505686
SIC: 2836 Biological Products, (No Diagnostic Substances)